Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.
Oct 2011 - Clin. Dev. Immunol.; 2011:1740-2530 [PMID:21969837]
[Bray SM] [Vujanovic L] [Butterfield LH]

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.
Dec 2010 - Curr Opin Investig Drugs; 11(12):2040-3429 [PMID:21154122]
[Butterfield LH] [Vujanovic L]